Nicholas J. Kenyon, MD, MAS; Celeste Kivler, RCP, RRT, CCRC; Samuel Louie, MD
Two pitfalls in everyday asthma care are that omalizumab is a new asthma treatment, and that it is not recommended by the 2007 NAEPP treatment guidelines.
Nicholas J. Kenyon, MD, MAS; Celeste Kivler, RCP, RRT, CCRC; Samuel Louie, MD
Two pitfalls in everyday asthma care are that omalizumab is a new asthma treatment, and that it is not recommended by the 2007 NAEPP treatment guidelines.
Nicholas J. Kenyon, MD, MAS; Celeste Kivler, RCP, RRT, CCRC; Samuel Louie, MD
Two pitfalls in everyday asthma care are that omalizumab is a new asthma treatment, and that it is not recommended by the 2007 NAEPP treatment guidelines.
